An Open-label, One-sequence, 3-period Study to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers.
Latest Information Update: 23 Nov 2021
At a glance
- Drugs Fimasartan (Primary) ; Indapamide (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
Most Recent Events
- 18 Nov 2021 Status changed from recruiting to completed.
- 02 Nov 2021 New trial record